 | Up a level |
Sahebnasagh, Adeleh and Saghafi, Fatemeh and Avan, Razieh and Khoshi, Amirhosein and Khataminia, Masoud and Safdari, Mohammadreza and Habtemariam, Solomon (2024) Corrigendum to "The prophylaxis and treatment potential of supplements for COVID-19" [Eur. J. Pharmacol. 887 (15 November 2020) 173530]. European journal of pharmacology.
Rezai Ghaleno, Hassan and Sahebnasagh, Adeleh and Saghafi, Fatemeh and Negintaji, Sina and Safdari, Mohammadreza (2021) Nitric Oxide and Immune Responses in Cancer: Searching for New Therapeutic Strategies. Curr Med Chem.
Sahebnasagh, Adele and Rezai Ghaleno, Hassan and Saghafi, Fatemeh and Mojtahedzadeh, Mojataba and Negarandeh, Reza and Safdari, Mohammadreza (2020) Pharmacological treatments of COVID-19. Pharmacol Rep.
Sahebnasagh, Adeleh and Rezai Ghaleno, Hassan and Najmeddin, Farhad and Najafi, Atabak and Safdari, Mohammadreza and Habtemariam, Solomon (2020) A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19. Arch Med Res.
Rezai Ghaleno, Hassan and Sahebnasagh, Adele and Saghafi, Fatemeh and Safdari, Mohammadreza (2020) Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19. journal of pharmacy therapeutics.
